Yield10 Bioscience Announces Collaboration with Rothamsted Research to Develop Advanced Technology for Producing Omega-3 Nutritional Oils in Camelina
November 12, 2020 15:10 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass. and HARPENDEN, U.K., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it has signed a collaboration...
Yield10 Bioscience to Announce Third Quarter 2020 Financial Results and Host a Conference Call on Thursday, November 12, 2020
November 05, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company, announced today that the Company will report its third quarter 2020...
Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties
October 28, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has begun field testing to evaluate the emergence...
Yield10 Bioscience Announces Completion of Harvesting for 2020 Field Test Program to Evaluate Novel Yield and Compositional Traits in Camelina and Canola
October 01, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it has completed the harvest for its 2020 Field Test...
Yield10 Bioscience Announces Participation at The H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
September 09, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C....
Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private Placement
August 26, 2020 13:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten...
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
August 22, 2020 21:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 22, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of...
Yield10 Bioscience Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
August 21, 2020 16:22 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of...
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021
August 17, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from...
Yield10 Bioscience Announces Second Quarter 2020 Financial Results
August 11, 2020 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June...